Related Experiment Videos
Cost-effectiveness of HIV therapies in different economic worlds
The AIDS Reader
|June 8, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
The British journal of dermatology·2020
Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
A double-masked, placebo-controlled evaluation of timolol in a gel vehicle.
Journal of glaucoma·2009
Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.
Clinical and experimental immunology·2004
Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.
Journal of health services research & policy·2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.
Health economics review·2026
Fever of unknown origin: cost of illness study.
Open medicine (Warsaw, Poland)·2026
The potential usefulness of health asset valuation to promote health among Korean employees.
Scientific reports·2026